Literature DB >> 33584366

Structural Imaging-Based Biomarkers for Detecting Craving and Predicting Relapse in Subjects With Methamphetamine Dependence.

Chang Qi1, Xiaobing Fan2, Sean Foxley2, Qiuxia Wu3, Jinsong Tang4,5, Wei Hao3, An Xie6, Jianbin Liu6, Zhijuan Feng3,7, Tieqiao Liu3, Yanhui Liao4,5.   

Abstract

Background: Craving is the predictor of relapse, and insula cortex (IC) is a critical neural substrate for craving and drug seeking. This study investigated whether IC abnormalities among MA users can detect craving state and predict relapse susceptibility.
Methods: A total of 142 subjects with a history of MA dependence completed structural MRI (sMRI) scans, and 30 subjects (10 subjects relapsed) completed 4-month follow-up scans. MA craving was measured by the Visual Analog Scale for Craving. Abnormalities of IC gray matter volume (GMV) between the subjects with and without craving were investigated by voxel-based morphometry (VBM). The receiver operating characteristic (ROC) analysis was performed for the region-of-interest (ROI) of IC GMV to assess the diagnostic accuracy.
Results: By comparing whole-brain volume maps, this study found that subjects without craving (n = 64) had a significantly extensive decrease in IC GMV (family-wise error correction, p < 0.05) than subjects with craving group (n = 78). The ROI of IC GMV had a significantly positive correlation with the craving scores reported by MA users. The ROC analysis showed a good discrimination (area under curve is 0.82/0.80 left/right) for IC GMV between the subjects with and without craving. By selecting Youden index cut-off point from whole model group, calculated sensitivity/specificity was equal to 78/70% and 70/75% for left and right IC, respectively. By applying the above optimal cut-off values to 30 follow-up subjects as validations, the results showed a similar sensitivity (73-80%) and specificity (73-80%) for detecting craving state as model group. For predicting relapse susceptibility, the sensitivity (50-55%) was low and the specificity (80-90%) was high. Conclusions: Our study provides the first evidence that sMRI may be used to diagnosis the craving state in MA users based on optimal cut-off values, which could be served as MRI bio-markers and an objective measure of craving state.
Copyright © 2021 Qi, Fan, Foxley, Wu, Tang, Hao, Xie, Liu, Feng, Liu and Liao.

Entities:  

Keywords:  biomarkers; craving; methamphetamine use; relapse; structural imaging

Year:  2021        PMID: 33584366      PMCID: PMC7874235          DOI: 10.3389/fpsyt.2020.599099

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  20 in total

1.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

2.  Addiction is a brain disease, and it matters.

Authors:  A I Leshner
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

3.  Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium.

Authors:  Marco Contreras; Francisco Ceric; Fernando Torrealba
Journal:  Science       Date:  2007-10-26       Impact factor: 47.728

4.  A fast diffeomorphic image registration algorithm.

Authors:  John Ashburner
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

Review 5.  Pharmacological treatments for methamphetamine addiction: current status and future directions.

Authors:  Javier Ballester; Gerald Valentine; Mehmet Sofuoglu
Journal:  Expert Rev Clin Pharmacol       Date:  2016-12-20       Impact factor: 5.045

6.  Measurement strategies: the visual analogue scale.

Authors:  C A Mottola
Journal:  Decubitus       Date:  1993-09

Review 7.  New findings on biological factors predicting addiction relapse vulnerability.

Authors:  Rajita Sinha
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 8.  The clinical significance of drug craving.

Authors:  Stephen T Tiffany; Jennifer M Wray
Journal:  Ann N Y Acad Sci       Date:  2011-12-16       Impact factor: 5.691

9.  Repetitive transcranial magnetic stimulation targeting the insular cortex for reduction of heavy drinking in treatment-seeking alcohol-dependent subjects: a randomized controlled trial.

Authors:  Irene Perini; Robin Kämpe; Theodor Arlestig; Hanna Karlsson; Andreas Löfberg; Michal Pietrzak; Abraham Zangen; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2019-11-11       Impact factor: 7.853

10.  Managing addiction as a chronic condition.

Authors:  Michael Dennis; Christy K Scott
Journal:  Addict Sci Clin Pract       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.